Cellular Therapy and Transplantation

Cellular Therapy and Transplantation is an international, peer-reviewed, Open Access journal which publishes articles in the fields of cellular and gene therapy and tissue transplantation. We welcome original research articles, review articles, short communications and clinical case reports. The major criteria for acceptance and publication of a manuscript are originality, high quality, scientific rigor, and interest to a wide audience of readers. The journal is issued in printed and digital version (www.cttjournal.com)

Editorial work, processing and publication of the articles are free of charge for the authors.

Papers accepted for publication in CTT are made available on this site at no charge to readers (Open Access). The articles published in CTT are provided under the following license: Creative Commons Attribution 3.0 Unported, http://creativecommons.org/licenses/by/3.0/ Authors retain the copyright of their contributions.

Volume 13, Number 1
03/31/2024

Editor-in-Chief
Kulagin A. D. (St. Petersburg, Russia)

Co-Editors-in-Chief
Wagemaker G. (Rotterdam, Netherlands)
Zander A. R. (Hamburg, Germany)

Deputy Editor
Fehse B. (Hamburg, Germany)

Managing Editor
Chukhlovin A. B. (St. Petersburg, Russia)

Editorial Board
Bachigalupo A. (Milano, Italy)
Burt R. K.(Chicago, USA)
Gale R. P. (London, UK)
Hehlmann R. (Weinheim, Germany)
Holzer D. (Frankfurt a.M., Germany)
Kroeger N. (Hamburg, Germany)
Lawitschka A. (Vienna, Austria)
Moiseev I. S. (St. Petersburg, Russia)
Nagler A. (Tel-Aviv, Israel)
Novichkova G. A. (Moscow, Russia)
Parovichnikova E. N. (Moscow, Russia)
Peric Z. (Rieka, Croatia)
Prokhortchouk E. B. (Moscow, Russia)
Zubarovskaya L. S. (St. Petersburg, Russia)

In this Issue

Point of view

Towards personal gene and cell therapy: accelerating factors and roadblocks on point-of-care production approach

Mikhail Yu. Samsonov^1,2, Andrey M. Lomonosov²

Review article

Clinical safety and efficacy of mesenchymal stem cell transplantation for the treatment of heart diseases: A narrative review

Amir Nejad-Moghaddam^1,2

Clinical studies

Daratumumab in post-transplantation pure red cell aplasia in adults

Ksenia S. Tsvirko, Yuriy N. Kuznetsov, Irina K. Golubovskaya, Anna G. Smirnova, Elena E. Lepik, Zarema K. Abdulkhalikova, Nikolay Y. Tsvetkov, Olga V. Pirogova, Ivan S. Moiseev, Alexander D. Kulagin

Stroke before hematopoietic stem cell transplantation is a possible risk factor for post-transplant adverse outcomes

Alexey Yu. Polushin, Iaroslav B. Skiba, Maria D. Vladovskaya, Ivan S. Moiseev, Alexander D. Kulagin

Experimental study

Effect of the size of polymer particles bearing protein antigen on the in vivo T-cellular immune response

Rodion G. Sakhabeev¹, Dmitry S. Polyakov², Viktor A. Korzhikov-Vlakh³, Ekaterina S. Sinitsyna^3,4, Galina A. Platonova⁴, Evgenia G. Korzhikova-Vlakh^3,4, Mikhail M. Shavlovsky²

Organizational issues

Effectiveness and safety of allogeneic hematopoietic stem cells transplantation in adult patients with blood disorders: a survey of expert opinion from the Russian transplantation centers

Mikhail Yu. Drokov¹, Ivan S. Moiseev^2,3, Julia A. Oleinik⁴, Irina V. Ishmatova⁵, Dmitry V. Motorin⁶, Julia S. Kitaeva^7,8, Natalia A. Zorina⁹, Sergey V. Gritsaev¹⁰, Natalia M. Nikiforova¹¹, Lyubov M. Petrova¹², Tatyana S. Kaporskaya¹², Galina D. Petrova¹¹, Sergey V. Voloshin¹⁰, Natalia V. Minaeva⁹, Tatiana S. Konstantinova^7,8, Ilya S. Zyuzgin⁵, Vadim V. Ptushkin⁴, Alexander D. Kulagin^2,3, Elena N. Parovichnikova¹